5VM
APRE icon

5AM Venture Management’s Aprea Therapeutics APRE Stock Holding History

5AM Venture Management’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,958
Closed -$3.16M – 13
2021
Q1 		$3.16M Sell
30,958
-37,925
-55% -$4.42M 0.57% 11
2020
Q4 		$6.78M Sell
68,883
-41,750
-38% -$19.9M 2.28% 8
2020
Q3 		$53.2M Hold
110,633
– – 14% 3
2020
Q2 		$85.8M Sell
110,633
-32,000
-22% -$21M 18.79% 2
2020
Q1 		$99.2M Hold
142,633
– – 30.7% 1
2019
Q4 		$131M Buy
+142,633
New +$78.6M 28.17% 1

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

5AM Venture Management's APRE Position: Q2 2021 in Review

5AM Venture Management sold out of Aprea Therapeutics (APRE) in Q2 2021, closing a stake of 30,958 shares — an estimated $3.16M sold.

5AM Venture Management first reported a position in APRE in Q4 2019 and held it in 6 quarters. The position peaked at $131M in Q4 2019. 50 funds tracked by Wall St. Rank hold APRE as of Q2 2021.

  • 5AM Venture Management reported no remaining Aprea Therapeutics position as of Q2 2021 after selling out during the quarter.
  • 5AM Venture Management sold 30,958 Aprea Therapeutics shares in Q2 2021, an estimated $3.16M.
  • 5AM Venture Management first reported a position in Aprea Therapeutics in Q4 2019 and held it in 6 quarters.
  • 5AM Venture Management's Aprea Therapeutics position peaked at $131M in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2021.

Based on 5AM Venture Management's 13F filing for Q2 2021, filed 16 Aug 2021.